Home - Products - Others - Other Targets - 2-Phenylethyl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside

2-Phenylethyl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside

CAS No. 239795-38-1

2-Phenylethyl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside( —— )

Catalog No. M32622 CAS No. 239795-38-1

Phenethyl sophoroside is a useful organic compound for research related to life sciences.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 551 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2-Phenylethyl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Phenethyl sophoroside is a useful organic compound for research related to life sciences.
  • Description
    Phenethyl sophoroside is a useful organic compound for research related to life sciences.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    239795-38-1
  • Formula Weight
    446.5
  • Molecular Formula
    C20H30O11
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Encequidar

    Encequidar is a potent and selective P-glycoprotein inhibitor. HM30181 to inhibit Pgp at the murine BBB.

  • Polygalasaponin F

    Polygalasaponin F has anti-neuroinflammatory activity, can inhibit the release of inflammatory cytokines TNF-α and NO induced by lipopolysaccharides (LPS) and reduce the expression of inducible nitric oxide synthases.

  • Alisol B 23-acetate

    Alisol B 23-acetate produces protective effect against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes.